from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1215c/-

LFCtreatmentdescriptionclass of inhibitor

-1.265

Amikacinug/mL Amikacintranslation

-1.262

Cap5-10ug/mL Capreomycintranslation

-3.111

Rox10-50 ug/mL Roxithromycintranslation

0.343

SM2-5 ug/mL Streptomycintranslation

-3.997

Tet5-10 ug/mL Tetracyclinetranslation

0.076

Rif0.2-5ug/mL Rifampicintranscription

-0.347

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.143

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.344

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.223

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.143

Clofazimine10-13 ug/mL Clofaziminerespiration

0.638

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.749

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.155

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.386

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.398

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.929

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.209

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.551

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.026

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.479

KCN5-20 ug/mL Potassium cyaniderespiration

0.566

NaN30.2-2 mM Sodium aziderespiration

1.832

Nigericin50 uM Nigericinrespiration

-0.773

TRC10-150 ug/mL Triclosanrespiration

-1.024

TRZ10-25 ug/mL Thioridazinerespiration

-1.861

Valinomycin0.5-10 uM Valinomycinrespiration

1.078

ZnSO42 mM ZnSO4respiration

0.432

menadione6-10 ug/mL Menadionerespiration

0.436

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.587

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.332

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.663

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.426

NRP_1Non-replicating persistence stage 1dosRassociated

0.328

Amp0.2mg/mL AmpicillincellWall

0.339

Cephalexin20-100 ug/mL CephalexincellWall

-0.126

Cerulenin0.32-5 ug/mL CerulenincellWall

0.599

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.417

EMB10-20 ug/mL EthambutolcellWall

0.203

Eta12-40 ug/mL EthionamidecellWall

0.544

INH0.2-0.4 ug/mL IsoniazidcellWall

0.639

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.805

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.470

BZA0.12 mg/mL BenzamidearomaticAmides

-0.404

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.073

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.734

H2O24 mM hydrogen peroxideDNAdamaging

0.007

Levo10 ug/mL LevofloxacinDNAdamaging

-0.135

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.819

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.075

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.523

UVUV-irradiationDNAdamaging

-1.760

ARP41-4 ug/mL Antitubercular compound ARP4?

0.419

Antimycin12.5-50 ug/mL Antimycin A?

0.642

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.929

PA_110-50 ug/mL Antitubercular compound PA-1?

0.683

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.593

PA8240.2-2 ug/mL PA-824?

-0.111

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.416

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.325

Verapamil50 uM Verapamil?

0.329

mercaptoethanol2 mM 2-Mercaptoethanol?

0.692

methoxatin10-20 ug/mL Methoxatin?